Table 3 Comparisons of log-transformed leptin and log-transformed A-FABP levels in adult onset MS patients with BMI < 50 to healthy controls
From: Increased leptin and A-FABP levels in relapsing and progressive forms of MS
Adjusted for batch and age | Adjusted for batch, age and BMI | ||
|---|---|---|---|
Leptin | Healthy controls | Reference | Reference |
Relapsing remitting MS | 0.74 +/− 0.27 (0.007) | 0.38 +/− 0.23 (0.098) | |
Secondary progressive MS | 1.07 +/− 0.33 (0.002) | 0.76 +/− 0.28 (0.0074) | |
Primary progressive MS | 0.22 +/− 0.33 (0.49) | −0.14 +/− 0.27 (0.61) | |
Four group comparison p-value | 0.003 | 0.014 | |
A-FABP | Healthy controls | Reference | Reference |
Relapsing remitting MS | 0.15 +/− 0.16 (0.37) | 0.058 +/− 0.16 (0.72) | |
Secondary progressive MS | 0.63 +/− 0.21 (0.003) | 0.54 +/− 0.20 (0.007) | |
Primary progressive MS | 0.33 +/− 0.17 (0.062) | 0.18 +/− 0.17 (0.30) | |
Four group comparison p-value | 0.020 | 0.062 |